AnalystAlan

higgmond Wrote:
-------------------------------------------------------
> I generally see JV's in the pharma space. Company
> A has a product but no salesforce or a product
> that is outside of it's sweetspot, while Company B
> has an existing saleforce that is currently
> selling products that are complementary to Company
> A's product.
>
> A&B form a JV whereby A contributes the product
> and B contributes the salesforce. Valuation of
> the overall JV would be same as any other entity,
> although you generally would assume that the JV
> has a finite life and adjust accordingly. Value
> to either side would depend on exactly how the
> proceeds are split during the life of the JV.


Thanks again!

Could you please recommend a couple of books perhaps? or websites that talk about JV valuation/ formation...etc?